Home > Insider Trading > Latest 13D and 13G Filings > 13G Filing (0001567619-20-010697)

Filing Details

Accession Number:: 0001567619-20-010697
Form Type:: 13G Filing
Publication Date:: 2020-05-18 18:10:37

Filed By:: Iliad Research & Trading, L.p.
Company:: Immune Therapeutics Inc. (OTCMKTS:IMUN)
Filing Date:: 2020-05-19
SEC Url:: 13G Filing

Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name	Sole Voting Power	Shared Voting Power	Sole Dispositive Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Iliad Research Trading	45,712	7	45,712	9	45,712	9.99 %
Iliad Management	45,712	7	45,712	9	45,712	9.99 %
Fife Trading, Inc. 36-4151891	45,712	7	45,712	9	45,712	9.99 %
John M Fife	45,712	7	45,712	9	45,712	9.99 %

Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

Immune Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value

(Title of Class of Securities)

45252A107

(CUSIP Number)

Calendar Year 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

x Rule 13d-1(c)

o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.

45252A107


1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Iliad Research & Trading, L.P. 11-3688679

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o

3	SEC USE ONLY



4	CITIZENSHIP OR PLACE OF ORGANIZATION

	Utah

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5	SOLE VOTING POWER

			45,712*

		6	SHARED VOTING POWER



		7	SOLE DISPOSITIVE POWER

			45,712*

		8	SHARED DISPOSITIVE POWER



9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	45,712*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

	o

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	9.99*%

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

	PN
	FOOTNOTES

	* Reporting Person Iliad Research & Trading, L.P. (“Iliad”) has rights, under a Convertible Promissory Note to own an aggregate number of shares of the Issuer’s common stock which, except for a contractual cap on the amount of outstanding shares of the Issuer's common stock that Iliad may own, would exceed such a cap. Thus, the number of shares of the Issuer’s common stock beneficially owned by Iliad as of the date of this filing was 45,712 shares, which is 9.99% of the Issuer's 457,578 shares that were outstanding as of May 14, 2020 (as reported in the Issuer’s Form 10-K filed on that date).

CUSIP No.

45252A107


1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Iliad Management, LLC 20-0411071

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o

3	SEC USE ONLY



4	CITIZENSHIP OR PLACE OF ORGANIZATION

	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5	SOLE VOTING POWER

			45,712*

		6	SHARED VOTING POWER



		7	SOLE DISPOSITIVE POWER

			45,712*

		8	SHARED DISPOSITIVE POWER



9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	45,712*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

	o

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	9.99*%

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

	OO
	FOOTNOTES

	* Reporting person Iliad Management, LLC is the General Partner of reporting person Iliad. Iliad has rights, under a Convertible Promissory Note to own an aggregate number of shares of the Issuer’s common stock which, except for a contractual cap on the amount of outstanding shares of the Issuer's common stock that Iliad may own, would exceed such a cap. Thus, the number of shares of the Issuer’s common stock beneficially owned by Iliad as of the date of this filing was 45,712 shares, which is 9.99% of the Issuer's 457,578 shares that were outstanding as of May 14, 2020 (as reported in the Issuer’s Form 10-K filed on that date).

CUSIP No.

45252A107


1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Fife Trading, Inc. 36-4151891

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o

3	SEC USE ONLY



4	CITIZENSHIP OR PLACE OF ORGANIZATION

	Illinois

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5	SOLE VOTING POWER

			45,712*

		6	SHARED VOTING POWER



		7	SOLE DISPOSITIVE POWER

			45,712*

		8	SHARED DISPOSITIVE POWER



9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	45,712*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

	o

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	9.99*%

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

	CO
	FOOTNOTES

	* Reporting person Fife Trading, Inc. is the Manager of Iliad Management, LLC, which is the General Partner of reporting person Iliad. Iliad has rights, under a Convertible Promissory Note to own an aggregate number of shares of the Issuer’s common stock which, except for a contractual cap on the amount of outstanding shares of the Issuer's common stock that Iliad may own, would exceed such a cap. Thus, the number of shares of the Issuer’s common stock beneficially owned by Iliad as of the date of this filing was 45,712 shares, which is 9.99% of the Issuer's 457,578 shares that were outstanding as of May 14, 2020 (as reported in the Issuer’s Form 10-K filed on that date).

CUSIP No.

45252A107


1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	John M Fife

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o

3	SEC USE ONLY



4	CITIZENSHIP OR PLACE OF ORGANIZATION

	United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5	SOLE VOTING POWER

			45,712*

		6	SHARED VOTING POWER



		7	SOLE DISPOSITIVE POWER

			45,712*

		8	SHARED DISPOSITIVE POWER



9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	45,712*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

	o

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	9.99*%

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

	IN
	FOOTNOTES

	* John Fife is the President of Fife Trading, Inc., which is the Manager of Iliad Management, LLC, which is the General Partner of reporting person Iliad. Iliad has rights, under a Convertible Promissory Note to own an aggregate number of shares of the Issuer’s common stock which, except for a contractual cap on the amount of outstanding shares of the Issuer's common stock that Iliad may own, would exceed such a cap. Thus, the number of shares of the Issuer’s common stock beneficially owned by Iliad as of the date of this filing was 45,712 shares, which is 9.99% of the Issuer's 457,578 shares that were outstanding as of May 14, 2020 (as reported in the Issuer’s Form 10-K filed on that date).

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	Iliad Research and Trading, LP

Date: May 18, 2020	By:	/s/ John M Fife
		Name: John M Fife
		Title: President

	Iliad Management, LLC

Date: May 18, 2020	By:	/s/ John M Fife
		Name: John M Fife
		Title: President

	Fife Trading, Inc.

Date: May 18, 2020	By:	/s/ John M Fife
		Name: John M Fife
		Title: President



Date: May 18, 2020	By:	/s/ John M Fife
		Name: John M Fife

Footnotes:

Attention:

Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)